Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure

AIM: Portal hypertension is a common complication of liver cirrhosis and significantly increases mortality and morbidity. Previous reports have suggested that the compound thalidomide attenuates portal hypertension (PHT). However, the mechanism for this action is not fully elucidated. One hypothesis...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:World J Gastroenterol
Main Authors: Theodorakis, Nicholas G, Wang, Yining N, Korshunov, Vyacheslav A, Maluccio, Mary A, Skill, Nicholas J
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2015
Teme:
Basic Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394073/
https://ncbi.nlm.nih.gov/pubmed/25892862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4126
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki